CLINICAL_TRIALS trial_result · 2024-11-15

Clinical Trial Update: A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.

TAK-660 has completed a study evaluating its use in surgical procedures for people with Hemophilia A, with results posted on 2024-11-15.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Takeda | Conditions: Hemophilia A | Status: COMPLETED | Results posted: 2024-11-15